The world of clinical research is vast, but how do we distinguish between a study that is merely published and evidence that is truly trustworthy? On Monday, April 20, 2026 , the Cochrane Maternal, Newborn and Child Health (MNCH) group invites you to a vital conversation titled "From Trials to Trust: Evaluating and Applying Trustworthy Clinical Evidence". This virtual Grand Rounds session will bring together a global panel of experts to discuss how evidence is evaluated for trustworthiness and the implications for real-world decision-making.

What is Cochrane US?

Cochrane US is a key regional arm of the global Cochrane network, a non-profit organization dedicated to organizing medical research findings to facilitate evidence-based choices about health interventions. Cochrane US works to promote the use of high-quality evidence within the United States healthcare system, often collaborating with prestigious institutions like Harvard's Beth Israel Deaconess Medical Center (BIDMC) and the University of Colorado. By focusing on research integrity and the synthesis of clinical trials, the organization ensures that healthcare providers and policymakers have access to unbiased, peer-reviewed data to improve patient outcomes.

Why This Session Matters?

The Cochrane MNCH group focuses specifically on the health outcomes of mothers, newborns, and children. In these fields, the stakes for clinical decisions are incredibly high. This session is particularly useful for clinicians, researchers, and students who want to move beyond simply reading trial results and begin understanding the "trustworthiness" of the data they consume. As the medical landscape becomes increasingly crowded with information, the ability to critically evaluate evidence is a crucial skill for ensuring patient safety and effective care.

Meet the Panel

The event features an esteemed international panel representing top-tier academic and global health institutions:

• Zarko Alfirevic, MD: Professor of Fetal and Maternal Medicine and Associate Pro-Vice-Chancellor (Clinical Affairs) at the University of Liverpool in England, UK.
• Doris Chou, MD: Medical Officer for Maternal Perinatal Health within the UN's Special Programme in Human Reproduction (HRP) in Geneva, Switzerland.
• Aris Papageorghiou, MBChB, MD, FRCOG: Professor of Fetal Medicine and Editor-in-Chief for BJOG: An International Journal of Obstetrics and Gynaecology in England, UK.
• Lisa Bero, PhD: Senior Research Integrity Editor at Cochrane and Affiliate Professor at the University of Colorado Anschutz, California, US.
• Ben Mol, MD, PhD: Professor and Head of Obstetrics and Gynaecology at Monash University in Melbourne, Australia.

Event Details:

• Date: Monday, April 20, 2026
• Time: 18:00–19:30 UTC
• Location: Virtual; attendees can register via Zoom here
• Questions? If you have topics or questions for this panel, please email bidmc-cochrane@bidmc.harvard.edu.

See you there!